PATENT CLAIM ANALYSIS

Application Number: 16270363
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["548", "557000"]

Abstract:
Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Claim (Index 7):
The method of  claim 2 , wherein said compound is or a pharmacologically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.83333
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16011050', '15724002', '15039964', '15576350', '11253812']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7879021273534447
- 35 USC 102 Novelty (BERT): 0.6037070176634338
- Combined Prediction Score: 0.7694826163844436
- Mean Citation Score: 471.121972
- Max Citation Score: 560.81244
- Similarity Product: 450.6075456249618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test